ForMED Ventures

ForMED Ventures targets early-stage healthcare and medical technology companies, with a particular focus on digital health platforms, medical devices, and diagnostics. The firm sources opportunities from Taiwan's biomedical research ecosystem and supports portfolio companies through clinical validation, regulatory strategy, and international market access.

The firm leverages deep relationships with Taiwan's academic medical centers, teaching hospitals, and the science-park-based biomedical R&D infrastructure. It identifies clinician-founded startups and university spinouts where technical validation has occurred but commercial translation remains early — a sourcing corridor that generalist venture firms often lack the clinical network to access effectively.

While ForMED is headquartered in Taipei and sources primarily from Taiwan's biomedical sector, its portfolio companies pursue global regulatory pathways including US FDA 510(k), CE marking, and FDA premarket approval. The firm facilitates distribution partnerships targeting Southeast Asia and North America as its portfolio companies scale commercially.

ForMED invests across seed and early venture stages — often serving as a first institutional check for medical device and digital health spinouts from Taiwanese research institutions. The firm will also participate in later-stage rounds for existing portfolio companies approaching regulatory milestones or international commercial entry.

ForMED maintains a healthcare-exclusive focus and does not pursue generalist technology, consumer, or enterprise SaaS investments outside life sciences and medical technology. Within healthcare, the firm has shown no disclosed activity in biopharmaceutical therapeutics, large-molecule drug development, or services businesses without a medical-device or diagnostic-technology core.